AJGP
HOME HELP FEEDBACK SUBSCRIPTIONS ALL ISSUES SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Geriatr Psychiatry 13:1006-1013, November 2005
© 2005 American Association for Geriatric Psychiatry
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a Colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kircher, T. T.J.
Right arrow Articles by Leube, D. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kircher, T. T.J.
Right arrow Articles by Leube, D. T.

Regular Article

Cortical Activation During Cholinesterase-Inhibitor Treatment in Alzheimer Disease

Preliminary Findings From a Pharmaco-fMRI Study

Tilo T.J. Kircher, M.D., Ph.D., Michael Erb, Ph.D., Wolfgang Grodd, M.D., Ph.D., and Dirk T. Leube, M.D.

Received March 21, 2004; revised August 13, September 3, 2004; accepted September 21, 2004. From the Dept. of Psychiatry, Univ. of Tübingen, Tübingen, Germany (TTJK, DTL), the Section of Experimental MRI of the CNS, Dept. of Neuroradiology, Univ. of Tübingen, Tübingen, Germany (ME, WG), and the Dept. of Psychiatry and Psychotherapy, Univ. of Aachen, Aachen, Germany (TTJK). Send correspondence and reprint requests to T. Kircher, M.D., Ph.D., Dept. of Psychiatry, RWTH Aachen University, Pauwelsstr. 30, D-52072 Aachen, Germany. e-mail: tkircher{at}ukaachen.de
© 2005 American Association for Geriatric Psychiatry

Objective: Cholinesterase inhibitors improve cognitive functioning in Alzheimer disease (AD). The authors studied, with functional magnetic resonance imaging (fMRI), the neural mechanism by which this cholinergic enhancement improves memory encoding in AD over longer time periods. Methods: Brain activation was measured in 10 patients with AD and 10 healthy elderly comparison subjects with fMRI while they were encoding novel faces. Patients were scanned again after a 10-week open treatment with the cholinesterase-inhibitor donepezil. Results: Neuropsychologically-tested memory performance improved during the treatment phase in the patients. During the encoding of novel faces, elderly comparison subjects showed more activation in the right fusiform gyrus than the group of AD patients. After a 10-week treatment with donepezil, the fusiform gyrus was also activated in patients, similar to the comparison group. Conclusions: The right fusiform gyrus is associated with the processing of faces. Cholinergic enhancement augments selective attention by increased selectivity of perceptual responses in patients with AD. This mechanism may contribute to a more efficient processing of the attended stimulus and thus be a mechanism underlying clinical improvement of cognitive functioning. These promising preliminary findings need to be confirmed in a larger, controlled trial in which both fMRI and attention measures serve as outcomes.

Key Words: Alzheimer Disease • fMRI • Cholinesterase Inhibitors. Donepezil




This article has been cited by other articles:


Home page
AJGPHome page
M. Pihlajamaki, K. M. DePeau, D. Blacker, and R. A. Sperling
Impaired Medial Temporal Repetition Suppression is Related to Failure of Parietal Deactivation in Alzheimer Disease
Am J Geriatr Psychiatry, April 1, 2008; 16(4): 283 - 292.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
T. T Kircher, S. Weis, K. Freymann, M. Erb, F. Jessen, W. Grodd, R. Heun, and D. T Leube
Hippocampal activation in patients with mild cognitive impairment is necessary for successful memory encoding
J. Neurol. Neurosurg. Psychiatry, August 1, 2007; 78(8): 812 - 818.
[Abstract] [Full Text] [PDF]


Home page
J Geriatr Psychiatry NeurolHome page
L. Minati, M. Grisoli, and M. G. Bruzzone
MR Spectroscopy, Functional MRI, and Diffusion-Tensor Imaging in the Aging Brain: A Conceptual Review
J Geriatr Psychiatry Neurol, March 1, 2007; 20(1): 3 - 21.
[Abstract] [PDF]


Home page
J. Neurosci.Home page
S. C. Johnson, T. W. Schmitz, M. A. Trivedi, M. L. Ries, B. M. Torgerson, C. M. Carlsson, S. Asthana, B. P. Hermann, and M. A. Sager
The influence of Alzheimer disease family history and apolipoprotein E epsilon4 on mesial temporal lobe activation.
J. Neurosci., May 31, 2006; 26(22): 6069 - 6076.
[Abstract] [Full Text] [PDF]


Home page
AJGPHome page
K. Yaffe
Research and Care of Patients With Dementia: Moving Beyond Memory Loss
Am J Geriatr Psychiatry, November 1, 2005; 13(11): 921 - 925.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ALL ISSUES SEARCH TABLE OF CONTENTS
Copyright © 2005 American Association for Geriatric Psychiatry